The worlds #1 website for end of day & historical stock data
wide range of exchanges, data formats, tools and services
API
NEW
HISTORICAL DATA
SYMBOL LISTS
MEMBERSHIP
REGISTER
LOG IN
Toggle navigation
HOME
Home Page
Download
Symbol Lists
Quote & Chart
Symbol Changes
Splits
Dividends
PRODUCTS & SERVICES
Membership Levels
Conversion Utility
API Service
Data Client
Historical Data
Fundamental Data
Commercial Feeds
Web Service
HOW TO
Advanced Get
AIQ
AMIBroker
EzyChart
MetaStock
OmniTrader
SuperCharts
TradeStation
SUPPORT
FAQ
Data Formats
Data Quality
Forgotten Password
Submit a Support Request
ABOUT
About Us
Contact Us
Terms & Conditions
Privacy Policy
Useful Links
MY ACCOUNT
Downloads
Account Details
API
Buy Historical Data
Billing History
Data Format
Daily Emails
Watchlists
NASDAQ, BDTX:
05 Sep 2025
LAST:
2.940
CHANGE:
0.07
OPEN:
2.890
HIGH:
3.010
ASK:
0.000
VOLUME:
602.6K
CHG(%):
2.44
PREV:
2.870
LOW:
2.870
BID:
0.000
CHART
Period:
End of Day
1 Minute
5 Minute
10 Minute
15 Minute
30 Minute
Hourly
Weekly
Monthly
Yearly
RECENT END OF DAY PRICES
Date
Open
High
Low
Close
Volume
05 Sep 25
2.890
3.010
2.870
2.940
602.6K
04 Sep 25
2.910
2.930
2.760
2.870
711.1K
03 Sep 25
2.820
2.950
2.760
2.880
682.3K
02 Sep 25
2.710
2.870
2.690
2.800
744.1K
29 Aug 25
2.850
2.850
2.690
2.750
565.6K
28 Aug 25
2.890
2.975
2.825
2.850
418.3K
27 Aug 25
2.880
2.955
2.860
2.870
459K
26 Aug 25
2.920
2.980
2.880
2.900
684.5K
25 Aug 25
2.910
2.960
2.850
2.870
630.3K
22 Aug 25
2.740
3.041
2.740
2.920
1.45M
COMPANY PROFILE
Name:
About:
Black Diamond Therapeutics, Inc., a clinical-stage oncology company, focuses on the discovery and development of MasterKey therapies for patients with genetically defined tumors. The company's lead product candidate is BDTX-1535, a brain-penetrant epidermal growth factor receptor MasterKey inhibitor, which is in Phase 2 clinical trial for the treatment of epidermal growth factor receptor mutant non-small cell lung cancer, as well as Phase 1 clinical trial to treat glioblastoma. It is also developing BDTX-4933, a brain-penetrant RAF MasterKey inhibitor targeting KRAS, NRAS, and BRAF alterations in solid tumors that is in Phase 1 clinical trial. In addition, the company is developing BDTX-4876, a MasterKey inhibitor of oncogenic FGFR2/3 mutations with selectivity versus FGFR1/4, which is in preclinical stage. The company was formerly known as ASET Therapeutics, Inc. and changed its name to Black Diamond Therapeutics, Inc. in January 2018. Black Diamond Therapeutics, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
Sector:
Healthcare
Industry:
Biotechnology
Address:
One Main Street, Cambridge, MA, United States, 02142
Website:
https://www.blackdiamondtherapeutics.com
CUSIP:
09203E105
CIK:
0001701541
ISIN:
US09203E1055
FIGI:
BBG00MS4Y0W9
SYMBOL HISTORY
Purchase End of Day History
for this symbol from Jan 01, 0001
Purchase Intraday History
for this symbol from Jan 01, 0001
Add to Watchlist
ADD TO WATCHLIST
Please select which Watchlist you would like to add this symbol to:
Watchlist:
DOWNLOAD DATA
Download stock quote history quickly and easily in a variety of formats to suit your needs.
Exchange:
American Stock Exchange
Australian Securities Exchange
Chicago Futures Exchange
Cryptocurrencies
EUREX Futures Exchange
Euronext - Amsterdam
Euronext - Brussels
Euronext - Lisbon
Euronext - Oslo
Euronext - Paris
Foreign Exchange
Frankfurt Exchange
Global Indices
LIFFE Futures and Options
London Stock Exchange
Madrid Stock Exchange
Minneapolis Grain Exchange
Mutual Funds
NASDAQ Stock Exchange
National Stock Exchange of India
New York Board of Trade
New York Stock Exchange
OTC Bulletin Board
Shanghai Stock Exchange
Shenzhen Stock Exchange
Singapore Stock Exchange
Toronto Stock Exchange
Toronto Venture Exchange
Winnipeg Commodity Exchange
Format:
3F VIP Trading
Advanced Get ASCII
AGet ASCII
AIQ Trading Expert Pro
Ami Broker
Ami Broker with Names
Andromeda
ASCII (Intraday)
EzyCharts
FCharts
FCharts (Intraday)
MetaStock ASCII (7 column)
MetaStock ASCII (8 column)
Metastock ASCII (Intraday)
MetaStock ASCII with Names
Personal Stock Streamer
Quicken
SpiffyCharts
Spreadsheet (eg: Excel)
Standard CSV
Stock Screener Pro
SuperCharts ASCII
Wal Data Platinum
Windows on Wallstreet
Period:
End of Day
1 Minute Bars
5 Minute Bars
10 Minute Bars
15 Minute Bars
30 Minute Bars
60 Minute Bars
Zip file
Symbol:
Start Date:
End Date:
Download
FUNDAMENTALS
P/E Ratio:
11.04
Price to Book:
1.14
Price to Sales:
2.16
EBITDA:
7.99M
Shares:
56.94M
Market Cap:
167.39M
TECHNICAL INDICATORS
MA5:
2.85
MA10:
2.87
MA20:
2.75
MA50:
2.77
MA100:
2.39
MA200:
2.25
STO9:
73.08
STO14:
77.10
RSI14:
59.78
MTM14:
0.19
ROC14:
0.07
ATR:
0.16
Week High:
3.01
Week Low:
2.69
Month High:
3.04
Month Low:
2.22
Year High:
6.33
Year Low:
1.20
Volatility:
8.88